Pre-Clinical Assessment of ¹⁷⁷Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease

By Ray Geoffrey L.   Baidoo Kwamena E.   Keller Lanea M. M.   Albert Paul S.   Brechbiel Martin W.   Milenic Diane E.  

Pharmaceuticals, Vol. 5, Iss. 1, 2011-12 ,pp. : 1-15

MDPI

Access to resources Recommend Favorite

Preparation of DOTA-TATE and DOTA-NOC freeze-dried kits for formulation of patient doses of ¹⁷⁷Lu-labeled agents and their comparison for peptide receptor radionuclide therapy application

By Das Tapas   Bhadwal Mohini   Banerjee Sharmila   Sarma H.   Shinto Ajit   Kamaleshwaran K.  

Journal of Radioanalytical and Nuclear Chemistry, Vol. 299, Iss. 3, 2014-03 ,pp. : 1389-1398

Springer Publishing Company

Access to resources Recommend Favorite

Production of ¹⁷⁷Lu by neutron activation of ¹⁷⁶Lu

By Nir-El Y.  

Journal of Radioanalytical and Nuclear Chemistry, Vol. 262, Iss. 3, 2005-01 ,pp. : 563-567

Springer Publishing Company

Access to resources Recommend Favorite

211At labeling of a monoclonal antibody and its Fab fragment: Cytotoxicity on human gastric cancer cells and biodistribution in nude mice with tumor xenografts

By Liu N.   Jin J.   Zhang S.   Mo S.   Yang Y.   Wang J.   Zhou M.  

Journal of Radioanalytical and Nuclear Chemistry, Vol. 247, Iss. 1, 2001-01 ,pp. : 129-133

Springer Publishing Company

Access to resources Recommend Favorite

Technology of DTPA and immunoglobulins conjugation and their attachment to ⁹⁰Y and ¹⁷⁷Lu radionuclides

By Reková M.   Budský F.   Miler V.   Málek Z.   Jedináková-Křížová V.  

Journal of Radioanalytical and Nuclear Chemistry, Vol. 286, Iss. 3, 2010-12 ,pp. : 853-859

Springer Publishing Company

Access to resources Recommend Favorite